Another study on Kras-mutant mice showed that treatment with anti-ST2 antibody could reduce Tregs in tumor, which led to restoration of NK cell activity and enhanced Th1 activity, with increased CD8+ T cell response (77). Here, CD8A is linked to neoplasm.